Romlusevimab

• Target :

  SARS-CoV

• Related Pathways :

  Microbiology/Virology

• Purity :

  1

• Bioactivity :

  Romlusevimab (BRII-198) is a recombinant antibody targeting the spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), with antiviral activity, used for research on COVID-19 infection.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2509447-08-7